Unknown

Dataset Information

0

Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

ABSTRACT:

SUBMITTER: Barus R 

PROVIDER: S-EPMC6715604 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Barus Romain R   Béné Johana J   Deguil Julie J   Gautier Sophie S   Bordet Régis R  

British journal of pharmacology 20190331 18

Similar Datasets

Unknown Rising midlife obesity will worsen future prevalence of dementia.
| S-EPMC4153475 | biostudies-literature
Unknown Polygenic pathways shape white matter vulnerability to Alzheimer's disease-related pathophysiological changes.
| S-EPMC12604407 | biostudies-literature
Unknown Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia.
| S-EPMC7272359 | biostudies-literature
Unknown CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.
| S-EPMC7504705 | biostudies-literature
Unknown Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
| S-EPMC11449142 | biostudies-literature
Unknown Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure.
| S-EPMC9302623 | biostudies-literature
Unknown Combined neuropathological pathways account for age-related risk of dementia.
| S-EPMC6119518 | biostudies-literature
Unknown Hospital Pharmacists' Perceptions and Decision-Making Related to Drug-Drug Interactions.
| S-EPMC6699872 | biostudies-literature
Unknown Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
| S-EPMC8286258 | biostudies-literature
Unknown Do hearing loss interventions prevent dementia?
| S-EPMC10289956 | biostudies-literature